カテゴリー： Market Monitor Global, 世界, 医療/バイオ

ナノ医薬品の世界市場見通し2023年-2029年

◆英語タイトル：Nanopharmaceutical Drugs Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5795）◆商品コード：MMG23JU5795
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：70
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥487,500見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥633,750見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥731,250見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Nanopharmaceutical Drugs Market 調査レポートは次の情報を含め、グローバルにおけるのナノ医薬品市場規模と予測を収録しています。・世界のナノ医薬品市場：売上、2018年-2023年、2024年-2029年
・世界のナノ医薬品市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のナノ医薬品市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「リポソーム」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

ナノ医薬品のグローバル主要企業は、Pfizer、 Merck、 AstraZeneca、 Gilead Sciences、 Abbvie、 Amgen、 Roche、 Novartis、 Sanofiなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、ナノ医薬品のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のナノ医薬品市場：タイプ別、2018年-2023年、2024年-2029年
世界のナノ医薬品市場：タイプ別市場シェア、2022年
・リポソーム、ポリマー、ナノクリスタル、タンパク質、その他

世界のナノ医薬品市場：用途別、2018年-2023年、2024年-2029年
世界のナノ医薬品市場：用途別市場シェア、2022年
・腫瘍学、神経学、免疫学、抗感染症、循環器学、その他

世界のナノ医薬品市場：地域・国別、2018年-2023年、2024年-2029年
世界のナノ医薬品市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるナノ医薬品のグローバル売上、2018年-2023年
・主要企業におけるナノ医薬品のグローバル売上シェア、2022年
・主要企業におけるナノ医薬品のグローバル販売量、2018年-2023年
・主要企業におけるナノ医薬品のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Pfizer、 Merck、 AstraZeneca、 Gilead Sciences、 Abbvie、 Amgen、 Roche、 Novartis、 Sanofi

*************************************************************

・調査・分析レポートの概要
ナノ医薬品市場の定義
市場セグメント
世界のナノ医薬品市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のナノ医薬品市場規模
世界のナノ医薬品市場規模：2022年 VS 2029年
世界のナノ医薬品市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのナノ医薬品の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のナノ医薬品製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：リポソーム、ポリマー、ナノクリスタル、タンパク質、その他
ナノ医薬品のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：腫瘍学、神経学、免疫学、抗感染症、循環器学、その他
ナノ医薬品の用途別グローバル売上・予測

・地域別市場分析
地域別ナノ医薬品市場規模 2022年と2029年
地域別ナノ医薬品売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Pfizer、 Merck、 AstraZeneca、 Gilead Sciences、 Abbvie、 Amgen、 Roche、 Novartis、 Sanofi
...

Nanopharmaceuticals are colloidal particles of 10 to 1,000 nanometers (1 micron) in size. They are widely used in drug delivery. Nanopharmaceuticals are diverse both in their shape and composition and often offer an advantage as compared to their “bulk” counterparts primarily because of size.

There are two types of nanopharmaceuticals: (1) those where the therapeutic molecules are themselves the drug (i.e.,the therapeutic compound itself also functions as its own carrier); and (2) those where the therapeutic molecules are directly coupled (functionalized, entrapped, or coated) to a nanoparticle carrier.
This report aims to provide a comprehensive presentation of the global market for Nanopharmaceutical Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nanopharmaceutical Drugs. This report contains market size and forecasts of Nanopharmaceutical Drugs in global, including the following market information:
Global Nanopharmaceutical Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Nanopharmaceutical Drugs Market Sales, 2018-2023, 2024-2029, (K MT)
Global top five Nanopharmaceutical Drugs companies in 2022 (%)
The global Nanopharmaceutical Drugs market was valued at US$ 31860 million in 2022 and is projected to reach US$ 54500 million by 2029, at a CAGR of 8.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
USA is the largest Nanopharmaceuticals market with about 59% market share. Europe is follower, accounting for about 33% market share.
The key players are Merck, Pfizer, Novartis, Abbott, GlaxoSmithKline, Roche, Sanofi, Eli Lilly, Astrazeneca, Johnson & Johnson, Celgene, Novavax, Stryker, Gilead Sciences, OSI Pharmaceuticals, Kadmon Pharmaceuticals, Samyang Biopharm, Mitsubishi Pharma, Kaken Pharmaceutical, Selecta Biosciences, Par Pharmaceutical, Cerulean Pharma, Navidea Biopharmaceuticals, Lummy etc. Top 3 companies occupied about 34% market share.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nanopharmaceutical Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nanopharmaceutical Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Nanopharmaceutical Drugs Market Segment Percentages, by Type, 2022 (%)
Liposomes
Polymer
Nanocrystals
Protein
Others
Global Nanopharmaceutical Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Nanopharmaceutical Drugs Market Segment Percentages, by Application, 2022 (%)
Oncology
Neurology
Immunology
Anti-Infective
Cardiovascular
Others
Global Nanopharmaceutical Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Nanopharmaceutical Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nanopharmaceutical Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Nanopharmaceutical Drugs revenues share in global market, 2022 (%)
Key companies Nanopharmaceutical Drugs sales in global market, 2018-2023 (Estimated), (K MT)
Key companies Nanopharmaceutical Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Merck
AstraZeneca
Gilead Sciences
Abbvie
Amgen
Roche
Novartis
Sanofi
Outline of Major Chapters:
Chapter 1: Introduces the definition of Nanopharmaceutical Drugs, market overview.
Chapter 2: Global Nanopharmaceutical Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Nanopharmaceutical Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nanopharmaceutical Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Nanopharmaceutical Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Nanopharmaceutical Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nanopharmaceutical Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nanopharmaceutical Drugs Overall Market Size
2.1 Global Nanopharmaceutical Drugs Market Size: 2022 VS 2029
2.2 Global Nanopharmaceutical Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Nanopharmaceutical Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Nanopharmaceutical Drugs Players in Global Market
3.2 Top Global Nanopharmaceutical Drugs Companies Ranked by Revenue
3.3 Global Nanopharmaceutical Drugs Revenue by Companies
3.4 Global Nanopharmaceutical Drugs Sales by Companies
3.5 Global Nanopharmaceutical Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Nanopharmaceutical Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Nanopharmaceutical Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Nanopharmaceutical Drugs Players in Global Market
3.8.1 List of Global Tier 1 Nanopharmaceutical Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Nanopharmaceutical Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Nanopharmaceutical Drugs Market Size Markets, 2022 & 2029
4.1.2 Liposomes
4.1.3 Polymer
4.1.4 Nanocrystals
4.1.5 Protein
4.1.6 Others
4.2 By Type – Global Nanopharmaceutical Drugs Revenue & Forecasts
4.2.1 By Type – Global Nanopharmaceutical Drugs Revenue, 2018-2023
4.2.2 By Type – Global Nanopharmaceutical Drugs Revenue, 2024-2029
4.2.3 By Type – Global Nanopharmaceutical Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Nanopharmaceutical Drugs Sales & Forecasts
4.3.1 By Type – Global Nanopharmaceutical Drugs Sales, 2018-2023
4.3.2 By Type – Global Nanopharmaceutical Drugs Sales, 2024-2029
4.3.3 By Type – Global Nanopharmaceutical Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Nanopharmaceutical Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Nanopharmaceutical Drugs Market Size, 2022 & 2029
5.1.2 Oncology
5.1.3 Neurology
5.1.4 Immunology
5.1.5 Anti-Infective
5.1.6 Cardiovascular
5.1.7 Others
5.2 By Application – Global Nanopharmaceutical Drugs Revenue & Forecasts
5.2.1 By Application – Global Nanopharmaceutical Drugs Revenue, 2018-2023
5.2.2 By Application – Global Nanopharmaceutical Drugs Revenue, 2024-2029
5.2.3 By Application – Global Nanopharmaceutical Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Nanopharmaceutical Drugs Sales & Forecasts
5.3.1 By Application – Global Nanopharmaceutical Drugs Sales, 2018-2023
5.3.2 By Application – Global Nanopharmaceutical Drugs Sales, 2024-2029
5.3.3 By Application – Global Nanopharmaceutical Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Nanopharmaceutical Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Nanopharmaceutical Drugs Market Size, 2022 & 2029
6.2 By Region – Global Nanopharmaceutical Drugs Revenue & Forecasts
6.2.1 By Region – Global Nanopharmaceutical Drugs Revenue, 2018-2023
6.2.2 By Region – Global Nanopharmaceutical Drugs Revenue, 2024-2029
6.2.3 By Region – Global Nanopharmaceutical Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Nanopharmaceutical Drugs Sales & Forecasts
6.3.1 By Region – Global Nanopharmaceutical Drugs Sales, 2018-2023
6.3.2 By Region – Global Nanopharmaceutical Drugs Sales, 2024-2029
6.3.3 By Region – Global Nanopharmaceutical Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Nanopharmaceutical Drugs Revenue, 2018-2029
6.4.2 By Country – North America Nanopharmaceutical Drugs Sales, 2018-2029
6.4.3 US Nanopharmaceutical Drugs Market Size, 2018-2029
6.4.4 Canada Nanopharmaceutical Drugs Market Size, 2018-2029
6.4.5 Mexico Nanopharmaceutical Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Nanopharmaceutical Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Nanopharmaceutical Drugs Sales, 2018-2029
6.5.3 Germany Nanopharmaceutical Drugs Market Size, 2018-2029
6.5.4 France Nanopharmaceutical Drugs Market Size, 2018-2029
6.5.5 U.K. Nanopharmaceutical Drugs Market Size, 2018-2029
6.5.6 Italy Nanopharmaceutical Drugs Market Size, 2018-2029
6.5.7 Russia Nanopharmaceutical Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Nanopharmaceutical Drugs Market Size, 2018-2029
6.5.9 Benelux Nanopharmaceutical Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Nanopharmaceutical Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Nanopharmaceutical Drugs Sales, 2018-2029
6.6.3 China Nanopharmaceutical Drugs Market Size, 2018-2029
6.6.4 Japan Nanopharmaceutical Drugs Market Size, 2018-2029
6.6.5 South Korea Nanopharmaceutical Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Nanopharmaceutical Drugs Market Size, 2018-2029
6.6.7 India Nanopharmaceutical Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Nanopharmaceutical Drugs Revenue, 2018-2029
6.7.2 By Country – South America Nanopharmaceutical Drugs Sales, 2018-2029
6.7.3 Brazil Nanopharmaceutical Drugs Market Size, 2018-2029
6.7.4 Argentina Nanopharmaceutical Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Nanopharmaceutical Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Nanopharmaceutical Drugs Sales, 2018-2029
6.8.3 Turkey Nanopharmaceutical Drugs Market Size, 2018-2029
6.8.4 Israel Nanopharmaceutical Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Nanopharmaceutical Drugs Market Size, 2018-2029
6.8.6 UAE Nanopharmaceutical Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Nanopharmaceutical Drugs Major Product Offerings
7.1.4 Pfizer Nanopharmaceutical Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Nanopharmaceutical Drugs Major Product Offerings
7.2.4 Merck Nanopharmaceutical Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Merck Key News & Latest Developments
7.3 AstraZeneca
7.3.1 AstraZeneca Company Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Nanopharmaceutical Drugs Major Product Offerings
7.3.4 AstraZeneca Nanopharmaceutical Drugs Sales and Revenue in Global (2018-2023)
7.3.5 AstraZeneca Key News & Latest Developments
7.4 Gilead Sciences
7.4.1 Gilead Sciences Company Summary
7.4.2 Gilead Sciences Business Overview
7.4.3 Gilead Sciences Nanopharmaceutical Drugs Major Product Offerings
7.4.4 Gilead Sciences Nanopharmaceutical Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Gilead Sciences Key News & Latest Developments
7.5 Abbvie
7.5.1 Abbvie Company Summary
7.5.2 Abbvie Business Overview
7.5.3 Abbvie Nanopharmaceutical Drugs Major Product Offerings
7.5.4 Abbvie Nanopharmaceutical Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Abbvie Key News & Latest Developments
7.6 Amgen
7.6.1 Amgen Company Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Nanopharmaceutical Drugs Major Product Offerings
7.6.4 Amgen Nanopharmaceutical Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Amgen Key News & Latest Developments
7.7 Roche
7.7.1 Roche Company Summary
7.7.2 Roche Business Overview
7.7.3 Roche Nanopharmaceutical Drugs Major Product Offerings
7.7.4 Roche Nanopharmaceutical Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Roche Key News & Latest Developments
7.8 Novartis
7.8.1 Novartis Company Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Nanopharmaceutical Drugs Major Product Offerings
7.8.4 Novartis Nanopharmaceutical Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Novartis Key News & Latest Developments
7.9 Sanofi
7.9.1 Sanofi Company Summary
7.9.2 Sanofi Business Overview
7.9.3 Sanofi Nanopharmaceutical Drugs Major Product Offerings
7.9.4 Sanofi Nanopharmaceutical Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Sanofi Key News & Latest Developments
8 Global Nanopharmaceutical Drugs Production Capacity, Analysis
8.1 Global Nanopharmaceutical Drugs Production Capacity, 2018-2029
8.2 Nanopharmaceutical Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Nanopharmaceutical Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Nanopharmaceutical Drugs Supply Chain Analysis
10.1 Nanopharmaceutical Drugs Industry Value Chain
10.2 Nanopharmaceutical Drugs Upstream Market
10.3 Nanopharmaceutical Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Nanopharmaceutical Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Nanopharmaceutical Drugs in Global Market
Table 2. Top Nanopharmaceutical Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Nanopharmaceutical Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Nanopharmaceutical Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Nanopharmaceutical Drugs Sales by Companies, (K MT), 2018-2023
Table 6. Global Nanopharmaceutical Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Nanopharmaceutical Drugs Price (2018-2023) & (USD/MT)
Table 8. Global Manufacturers Nanopharmaceutical Drugs Product Type
Table 9. List of Global Tier 1 Nanopharmaceutical Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nanopharmaceutical Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Nanopharmaceutical Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Nanopharmaceutical Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Nanopharmaceutical Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Nanopharmaceutical Drugs Sales (K MT), 2018-2023
Table 15. By Type - Global Nanopharmaceutical Drugs Sales (K MT), 2024-2029
Table 16. By Application – Global Nanopharmaceutical Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Nanopharmaceutical Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Nanopharmaceutical Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Nanopharmaceutical Drugs Sales (K MT), 2018-2023
Table 20. By Application - Global Nanopharmaceutical Drugs Sales (K MT), 2024-2029
Table 21. By Region – Global Nanopharmaceutical Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Nanopharmaceutical Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Nanopharmaceutical Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Nanopharmaceutical Drugs Sales (K MT), 2018-2023
Table 25. By Region - Global Nanopharmaceutical Drugs Sales (K MT), 2024-2029
Table 26. By Country - North America Nanopharmaceutical Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Nanopharmaceutical Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Nanopharmaceutical Drugs Sales, (K MT), 2018-2023
Table 29. By Country - North America Nanopharmaceutical Drugs Sales, (K MT), 2024-2029
Table 30. By Country - Europe Nanopharmaceutical Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Nanopharmaceutical Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Nanopharmaceutical Drugs Sales, (K MT), 2018-2023
Table 33. By Country - Europe Nanopharmaceutical Drugs Sales, (K MT), 2024-2029
Table 34. By Region - Asia Nanopharmaceutical Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Nanopharmaceutical Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Nanopharmaceutical Drugs Sales, (K MT), 2018-2023
Table 37. By Region - Asia Nanopharmaceutical Drugs Sales, (K MT), 2024-2029
Table 38. By Country - South America Nanopharmaceutical Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Nanopharmaceutical Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Nanopharmaceutical Drugs Sales, (K MT), 2018-2023
Table 41. By Country - South America Nanopharmaceutical Drugs Sales, (K MT), 2024-2029
Table 42. By Country - Middle East & Africa Nanopharmaceutical Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Nanopharmaceutical Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Nanopharmaceutical Drugs Sales, (K MT), 2018-2023
Table 45. By Country - Middle East & Africa Nanopharmaceutical Drugs Sales, (K MT), 2024-2029
Table 46. Pfizer Company Summary
Table 47. Pfizer Nanopharmaceutical Drugs Product Offerings
Table 48. Pfizer Nanopharmaceutical Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 49. Pfizer Key News & Latest Developments
Table 50. Merck Company Summary
Table 51. Merck Nanopharmaceutical Drugs Product Offerings
Table 52. Merck Nanopharmaceutical Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 53. Merck Key News & Latest Developments
Table 54. AstraZeneca Company Summary
Table 55. AstraZeneca Nanopharmaceutical Drugs Product Offerings
Table 56. AstraZeneca Nanopharmaceutical Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 57. AstraZeneca Key News & Latest Developments
Table 58. Gilead Sciences Company Summary
Table 59. Gilead Sciences Nanopharmaceutical Drugs Product Offerings
Table 60. Gilead Sciences Nanopharmaceutical Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 61. Gilead Sciences Key News & Latest Developments
Table 62. Abbvie Company Summary
Table 63. Abbvie Nanopharmaceutical Drugs Product Offerings
Table 64. Abbvie Nanopharmaceutical Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 65. Abbvie Key News & Latest Developments
Table 66. Amgen Company Summary
Table 67. Amgen Nanopharmaceutical Drugs Product Offerings
Table 68. Amgen Nanopharmaceutical Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 69. Amgen Key News & Latest Developments
Table 70. Roche Company Summary
Table 71. Roche Nanopharmaceutical Drugs Product Offerings
Table 72. Roche Nanopharmaceutical Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 73. Roche Key News & Latest Developments
Table 74. Novartis Company Summary
Table 75. Novartis Nanopharmaceutical Drugs Product Offerings
Table 76. Novartis Nanopharmaceutical Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 77. Novartis Key News & Latest Developments
Table 78. Sanofi Company Summary
Table 79. Sanofi Nanopharmaceutical Drugs Product Offerings
Table 80. Sanofi Nanopharmaceutical Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 81. Sanofi Key News & Latest Developments
Table 82. Nanopharmaceutical Drugs Production Capacity (K MT) of Key Manufacturers in Global Market, 2021-2023 (K MT)
Table 83. Global Nanopharmaceutical Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 84. Global Nanopharmaceutical Drugs Production by Region, 2018-2023 (K MT)
Table 85. Global Nanopharmaceutical Drugs Production by Region, 2024-2029 (K MT)
Table 86. Nanopharmaceutical Drugs Market Opportunities & Trends in Global Market
Table 87. Nanopharmaceutical Drugs Market Drivers in Global Market
Table 88. Nanopharmaceutical Drugs Market Restraints in Global Market
Table 89. Nanopharmaceutical Drugs Raw Materials
Table 90. Nanopharmaceutical Drugs Raw Materials Suppliers in Global Market
Table 91. Typical Nanopharmaceutical Drugs Downstream
Table 92. Nanopharmaceutical Drugs Downstream Clients in Global Market
Table 93. Nanopharmaceutical Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Nanopharmaceutical Drugs Segment by Type in 2022
Figure 2. Nanopharmaceutical Drugs Segment by Application in 2022
Figure 3. Global Nanopharmaceutical Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Nanopharmaceutical Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Nanopharmaceutical Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Nanopharmaceutical Drugs Sales in Global Market: 2018-2029 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Nanopharmaceutical Drugs Revenue in 2022
Figure 9. By Type - Global Nanopharmaceutical Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Nanopharmaceutical Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Nanopharmaceutical Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Nanopharmaceutical Drugs Price (USD/MT), 2018-2029
Figure 13. By Application - Global Nanopharmaceutical Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Nanopharmaceutical Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Nanopharmaceutical Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Nanopharmaceutical Drugs Price (USD/MT), 2018-2029
Figure 17. By Region - Global Nanopharmaceutical Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Nanopharmaceutical Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Nanopharmaceutical Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Nanopharmaceutical Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Nanopharmaceutical Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Nanopharmaceutical Drugs Sales Market Share, 2018-2029
Figure 23. US Nanopharmaceutical Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Nanopharmaceutical Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Nanopharmaceutical Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Nanopharmaceutical Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Nanopharmaceutical Drugs Sales Market Share, 2018-2029
Figure 28. Germany Nanopharmaceutical Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Nanopharmaceutical Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Nanopharmaceutical Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Nanopharmaceutical Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Nanopharmaceutical Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Nanopharmaceutical Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Nanopharmaceutical Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Nanopharmaceutical Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Nanopharmaceutical Drugs Sales Market Share, 2018-2029
Figure 37. China Nanopharmaceutical Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Nanopharmaceutical Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Nanopharmaceutical Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Nanopharmaceutical Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Nanopharmaceutical Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Nanopharmaceutical Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Nanopharmaceutical Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Nanopharmaceutical Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Nanopharmaceutical Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Nanopharmaceutical Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Nanopharmaceutical Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Nanopharmaceutical Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Nanopharmaceutical Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Nanopharmaceutical Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Nanopharmaceutical Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Nanopharmaceutical Drugs Production Capacity (K MT), 2018-2029
Figure 53. The Percentage of Production Nanopharmaceutical Drugs by Region, 2022 VS 2029
Figure 54. Nanopharmaceutical Drugs Industry Value Chain
Figure 55. Marketing Channels


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ ナノ医薬品の世界市場見通し2023年-2029年(Nanopharmaceutical Drugs Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • CAR T細胞型薬剤の世界市場見通し2023年-2029年
  • MSD医薬品の世界市場見通し2023年-2029年
  • IgA腎症治療薬の世界市場見通し2023年-2029年
  • 前頭洞炎治療薬の世界市場見通し2023年-2029年
  • オラパリブ薬の世界市場見通し2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆